Literature DB >> 9098030

Closing in on the signals of hepatic fibrosis.

S L Friedman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098030     DOI: 10.1016/s0016-5085(97)70158-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  7 in total

1.  Platelet-derived growth factor is a principal inductive factormodulating mannose 6-phosphate/insulin-like growth factor-II receptorgene expression via a distal E-box in activated hepatic stellate cells.

Authors:  J A Weiner; A Chen; B H Davis
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

Review 2.  Myofibroblasts: paracrine cells important in health and disease.

Authors:  D W Powell
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

3.  Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.

Authors:  Jean S Campbell; Steven D Hughes; Debra G Gilbertson; Thomas E Palmer; Matthew S Holdren; Aaron C Haran; Melissa M Odell; Renay L Bauer; Hong-Ping Ren; Harald S Haugen; Matthew M Yeh; Nelson Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

Review 4.  Evolving pathophysiologic concepts in nonalcoholic steatohepatitis.

Authors:  Brent A Neuschwander-Tetri
Journal:  Curr Gastroenterol Rep       Date:  2002-02

5.  Effects of silymarin and pentoxifylline on matrix metalloproteinase-1 and -2 expression and apoptosis in experimental hepatic fibrosis.

Authors:  Eray Kara; Teoman Coşkun; Yavuz Kaya; Okan Yumuş; Seda Vatansever; Ahmet Var
Journal:  Curr Ther Res Clin Exp       Date:  2008-12

6.  Expression of tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma.

Authors:  Y E Joo; Y H Seo; W S Lee; H S Kim; S K Choi; J S Rew; C S Park; S J Kim
Journal:  Korean J Intern Med       Date:  2000-12       Impact factor: 2.884

7.  Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.

Authors:  Cheng Liu; Xia Yuan; Le Tao; Zhuoan Cheng; Xiuqin Dai; Xia Sheng; Dongying Xue
Journal:  BMC Complement Altern Med       Date:  2015-06-30       Impact factor: 4.782

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.